Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

TVM Capital Life Science Venture Capital

Status
ACTIVE
Global HQ
California, United States
Countries of investment
  • United Kingdom
  • Singapore
Investment stages
  • Pre-Seed
  • Seed
Industries
  • Marketplaces
  • Fintech
  • Consumer Health
  • Enterprise Tech
  • Consumer Tech
  • Enterprise
  • E-Commerce
  • Cloud Computing
  • -
About
TVM Capital Life Science Venture Capital is dedicated to funding life science innovations with the potential to transform medical practice. The firm engages deeply with portfolio companies, leveraging a unique twopronged investment strategy. This includes financing innovative early stage therapeutics through a single asset company approach in partnership with Eli Lilly and Company, as Theyll as investing in differentiated commercialstage medtech, diagnostics, Digitalhealth products, and late stage therapeutics. With a significant track record and over 100 years of combined industry expertise, TVM supports the development and market introduction of groundbreaking medical products.
Min check size
$500K
Max check size
$10M
Fund size
NPS

Investment Thesis

TVM Capital Life Science focuses on life science innovations, investing in early stage therapeutics through strategic relationships, and differentiated commercialstage medtech, diagnostics, and Digitalhealth products
Lead investor
Co Invest
Number of exits
Preferred contact method

Portfolio

Natterhub

Learning Ladders

Occupational Therapy Kids

Education Lab

Music Monsters

Twin Science & Robotics

Cutting Hedge.

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp